References 28127 Pandey CK, Agarwal A, Baronia A, Singh N (2000). Toxicity of
ingested formalin and its management. Human Experiment. Toxicol.,
19 (6):360–66.
28 CDC (2015). Narcolepsy Following Pandemrix Influenza Vaccination in
Europe. https://www.cdc.gov/vaccinesafety/concerns/history/narcolepsy‐flu.
html. Accessed March 1, 2015.
29 Zerbo O, Klein NP, Croen LA (2017). Association between influenza infection
and vaccination during pregnancy and risk of autism spectrum disorder.
JAMA Pediatr., 171 (1):e163609.
30 Tomljenovic L, Shaw CA (2011). Aluminum vaccine adjuvants: are they safe?
Curr. Med. Chem., 18 (17):2630–37.
31 Agency for Toxic Substances and Disease Registry (ATSDR) (2008).
Toxicological Profile for Aluminum. US Department of Health and Human
Services, Atlanta, GA.
32 Israeli E, Agmon‐Levin N, Blank M, Shoenfeld Y (2011). Macrophagic
myofaciitis a vaccine (alum) autoimmune‐related disease. Clin. Rev. Allergy
Immunol. 41 :163–68.
33 Siegrist C‐A (2005). Vaccine adjuvants and macrophagic myofasciitis. Arch.
Péd. Organe Off. Soc. Fr. Péd., 12 :96–101.
34 Verdier F, Burnett R, Michelet‐Habchi C, et al. (2005). Aluminium assay and
evaluation of the local reaction at several time points after intramuscular
administration of aluminium containing vaccines in the Cynomolgus monkey.
Vaccine, 23 :1359–67.
35 WHO (2008). Statement from the Global Advisory Committee on Vaccine
Safety on Aluminium‐Containing Vaccines. http://www.who.int/vaccine_safety/
committee/topics/aluminium/statement_112002/en/. Accessed March 20, 2014.
36 Parpia R (2016). Polysorbate 80: A Risky Vaccine Ingredient. The Vaccine
Reaction. http://www.thevaccinereaction.org/2016/01/polysorbate‐80‐a‐risky‐
vaccine‐ingredient/. Accessed January 7, 2016.
37 Centers for Disease Control and Prevention. Centers for Disease Control and
Prevention (2014). Toxic Substances Portal – Phenol. https://www.atsdr.cdc.
gov/mmg/mmg.asp?id=144&tid=27. Accessed October 21, 2014.
38 Poudrier JK (1990). Final report on the safety assessment of phenoxyethanol.
J. Am. Coll. Toxicol., 9 (2):259–77.
39 Coors EA, Seybold H, Merk HF, Mahler V. (2005). Polysorbate 80 in medical
products and nonimmunologic anaphylactoid reactions. Ann. Allergy Asthma
Immunol., 95 (6):593–9.
40 Begg N (2013). Trust in vaccines: Why it takes more than good faith. Vaccines,
1 :343–7.
41 Thierry‐Carstensen B, Dalby T, Stevner MA, et al. (2013). Experience with
monocomponent acellular pertussis combination vaccines for infants,
children, adolescents and adults – a review of safety, immunogenicity,
efficacy and effectiveness studies and 15 years of field experience.
Vaccine, 31 (45):5178–91.